The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Suchkov S.V.

University of World Politics and Law;
Russian University of Medicine;
New York Academy of Sciences

Revishvili A.Sh.

Vishnevsky National Medical Research Center of Surgery of the Ministry of Health of Russia

Charchyan E.R.

Petrovsky National Research Centre of Surgery

Polyakova V.N.

University of World Politics and Law

Belov Yu.V.

Petrovsky National Research Center of Surgery;
Sechenov First Moscow State Medical University

Towards highly precise treatment and rehabilitation in practice of modern cardiologist, cardiac surgeon and cardiac rehabilitation professional

Authors:

Suchkov S.V., Revishvili A.Sh., Charchyan E.R., Polyakova V.N., Belov Yu.V.

More about the authors

Journal: Russian Journal of Cardiology and Cardiovascular Surgery. 2025;18(3): 343‑350

DOI: 10.17116/kardio202518031343

Read: 764 times

Buy for 300₽
Contact the author
Table of contents

TOWARDS HIGHLY PRECISE TREATMENT AND REHABILITATION IN PRACTICE OF MODERN CARDIOLOGIST, CARDIAC SURGEON AND CARDIAC REHABILITATION PROFESSIONAL
TOWARDS HIGHLY PRECISE TREATMENT AND REHABILITATION IN PRACTICE OF MODERN CARDIOLOGIST, CARDIAC SURGEON AND CARDIAC REHABILITATION PROFESSIONAL

To cite this article:

Suchkov SV, Revishvili ASh, Charchyan ER, Polyakova VN, Belov YuV. Towards highly precise treatment and rehabilitation in practice of modern cardiologist, cardiac surgeon and cardiac rehabilitation professional. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;18(3):343‑350. (In Russ.)
https://doi.org/10.17116/kardio202518031343

Подписка 2026 Кардиология и сердечно-сосудистая хирургия (Russian Journal of Cardiology and Cardiovascular Surgery)
МСФ на ЯМ
Использование инфографики авторами научных работ
Recommended articles:
On the path to personalized cardiology: prospects of precise asse­ssment of cardiovascular risks and predictive-prognostic diagnostics. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(2):206-215
Auto­logous adipose-derived stem cells for the treatment of complex cryptoglandular fistula (systematic review and meta-analysis). Plastic Surgery and Aesthetic Medi­cine. 2025;(2):117-127
Cere­bral microangiopathy. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(7):15-24
The type 1 diabetes mellitus treatment. Russian Journal of Preventive Medi­cine. 2025;(8):131-137
Biomarkers of aging mechanisms. Problems of Balneology, Physiotherapy and Exercise Therapy. 2025;(5-2):108-119
Abstract:

Despite the numerous efforts and progress in the treatment of cardiovascular diseases (CVDs), the last ones are still the leading cause of mortality. CVDs account for ~32% of all deaths worldwide, and the key cause is end-stage heart failure. In the last decade, stem cells with different differentiation have become a promising treatment for some diseases, including CVDs, not only due to their plasticity, but also due to effect on damaged tissues in paracrine manner. The last one promotes tissue regeneration and repair. This review will consider modern methods of therapy of CVDs using the latest (design) resources of personalized and precision medicine (PPM), as well as promising ways of targeted pharmacotherapy and regenerative medicine in cardiology, cardiac surgery and cardiac rehabilitation.

Keywords:

personalized and preventive medicine
personalized cardiology
omics technologies
cardiac rehabilitation
stem cells
apoptotic bodies

Authors:

Suchkov S.V.

University of World Politics and Law;
Russian University of Medicine;
New York Academy of Sciences

Revishvili A.Sh.

Vishnevsky National Medical Research Center of Surgery of the Ministry of Health of Russia

Charchyan E.R.

Petrovsky National Research Centre of Surgery

Polyakova V.N.

University of World Politics and Law

Belov Yu.V.

Petrovsky National Research Center of Surgery;
Sechenov First Moscow State Medical University

Received:

18.04.2024

Accepted:

23.05.2024

Close metadata

References:

  1. Debbage P. Targeted drugs and nanomedicine: present and future. Curr Pharm Des. 2009;15(2):153-172.  https://doi.org/10.2174/138161209787002870
  2. Zuurbier CJ, Bertrand L, Beauloye CR, et al. Cardiac metabolism as a driver and therapeutic target of myocardial infarction. J Cell Mol Med. 2020;24(11):5937-5954. https://doi.org/10.1111/jcmm.15180
  3. Currie G, Delles C. Precision Medicine and Personalized Medicine in Cardiovascular Disease. Adv Exp Med Biol. 2018;1065:589-605.  https://doi.org/10.1007/978-3-319-77932-4_36
  4. Leopold JA, Loscalzo J. Emerging Role of Precision Medicine in Cardiovascular Disease. Circ Res. 2018;122(9):1302-1315. https://doi.org/10.1161/CIRCRESAHA.117.310782
  5. Lee LY, Pandey AK, Maron BA, Loscalzo J. Network medicine in Cardiovascular Research. Cardiovasc Res. 2021;117(10):2186-2202. https://doi.org/10.1093/cvr/cvaa321
  6. He L, Nguyen NB, Ardehali R, Zhou B. Heart Regeneration by Endogenous Stem Cells and Cardiomyocyte Proliferation: Controversy, Fallacy, and Progress. Circulation. 2020 July 21;142(3): 275-291.  https://doi.org/10.1161/CIRCULATIONAHA.119.045566
  7. Uygur A, Lee RT. Mechanisms of Cardiac Regeneration. Dev Cell. 2016 Feb 22;36(4):362-374.  https://doi.org/10.1016/j.devcel.2016.01.018
  8. Behfar A, Crespo-Diaz R, Terzic A, Gersh BJ. Cell therapy for cardiac repair-lessons from clinical trials. Nat Rev Cardiol. 2014;11(4): 232-246.  https://doi.org/10.1038/nrcardio.2014.9
  9. Cambria E, Steiger J, Günter J, Bopp A, Wolint P, Hoerstrup SP, Emmert MY. Cardiac Regenerative Medicine: The Potential of a New Generation of Stem Cells. Transfus Med Hemother. 2016; 43(4):275-281.  https://doi.org/10.1159/000448179
  10. Ichimura H, Chino S, Shiba Y. Cardiac Regeneration Using Pluripotent Stem Cells and Controlling Immune Responses. Heart Lung Circ. 2023 Jul;32(7):836-843.  https://doi.org/10.1016/j.hlc.2022.12.014
  11. Lamb EK, Kao GW, Kao RL. Cellular cardiomyoplasty: its past, present, and future. Methods Mol Biol. 2013;1036:1-17.  https://doi.org/10.1007/978-1-62703-511-8_1
  12. Gao L, Gregorich ZR, Zhu W, et al. Large Cardiac Muscle Patches Engineered From Human Induced-Pluripotent Stem Cell-Derived Cardiac Cells Improve Recovery From Myocardial Infarction in Swine. Circulation. 2018 Apr 17;137(16):1712-1730. https://doi.org/10.1161/CIRCULATIONAHA.117.030785
  13. Menasché P, Vanneaux V, Fabreguettes JR, et al. Towards a clinical use of human embryonic stem cell-derived cardiac progenitors: a translational experience. Eur Heart J. 2015;36(12):743-750.  https://doi.org/10.1093/eurheartj/ehu192
  14. Tyukavin AI, Belostotskaya GB, Zakharov EA, Ivkin DY, Rad’ko SV, Knyazev NA, Klimenko VV, Bogdanov AA, Suchkov SV. Apoptotic Bodies of Cardiomyocytes and Fibroblasts — Regulators of Directed Differentiation of Heart Stem Cells. Bull Exp Biol Med. 2020 Nov;170(1):112-117.  https://doi.org/10.1007/s10517-020-05015-0
  15. Belostotskaya G. Intracellular development of cardiac stem cells as a strategic avenue to se-cure self-renewal, regeneration and maintenance of the mammalian myocardium. Proceedings of 5th International conference on Clinical and Experimental Cardiology, April 27-29, 2015, Philadelphia, USA. J Clin Exp Cardiolog. 2015;6(4):75.  https://doi.org/10.3390/life11080723
  16. Belostotskaya G, Sonin D, Galagudza M. Intracellular Development of Resident Cardiac Stem Cells: An Overlooked Phenomenon in Myocardial Self-Renewal and Regeneration. Life (Basel). 2021 July 21;11(8):723.  https://doi.org/10.3390/life11080723
  17. Suárez-Cuenca JA, Robledo-Nolasco R, Alcántara-Meléndez MA, Díaz-Hernandez LJ, Vera-Gómez E, Hernández-Patricio A, Sánchez-Díaz KS, Gutiérrez-Buendía JA, Contreras-Ramos A, Ruíz-Hernández AS, Pérez-Cabeza de Vaca R, Mondragón-Terán P. Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty. J Vis Exp. 2020 Jan 28; (155). PMID: 32065158. https://doi.org/10.3791/60504
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.